Cell Surface Markers Market Is Expected To Reach US$ 33,712.7 Mn By 2026

Cell Surface Markers Market - Growth, Size, Share, Forecast, industry Analysis 2018 - 2026

The latest market report published by Credence Research, Inc. “Global Cell Surface Markers Market - Growth, Future Prospects, Competitive Analysis, 2018 - 2026,” the global cell surface markers market was valued at US$ 16,586.7 Mn in 2017, and is expected to reach US$ 33,712.7 Mn by 2026, expanding at a CAGR of 8.2% from 2018 to 2026.

Market Insights

According to the research findings of World Health Organization (WHO) by 2020, chronic diseases will be responsible for three quarters of death worldwide. Cell surface markers are proteins which are expressed on the surface of the cells which is useful in identifying the cell type. Cell surface markers are present for B lymphocytes, T lymphocytes, and cluster of differentiation (CD34+, CD4, CD19 etc).

Download Free brochure of research report with TOC and Figures @  https://www.credenceresearch.com/sample-request/59319

The major players dominating the cell surface markers market are Abbott Laboratories, Inc., Beckman Coulter, Inc., BD Biosciences, Bio-Rad Laboratories, Inc., F.Hoffman La-Roche AG, Grifols SA, Immucor, Inc., Janssen Diagnostics, Inc., Nihon Kohden Corporation and Thermo Fischer Scientific, Inc.

Showing 1 reaction

Please check your e-mail for a link to activate your account.